Navigation Links
Collaborative Drug Discovery Receives New Funding to Support Tuberculosis Drug Discovery Screening Efforts and Industrial-Academic Collaborations
Date:1/13/2011

BURLINGAME, Calif., Jan. 13, 2011 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD) today announced that the Bill & Melinda Gates Foundation has extended its previous grant to CDD to create a novel database to spark collaborative efforts to discover more effective drugs against tuberculosis (TB). The TB bacillus infects approximately one third of the world's population and the disease kills over 1.5 million people every year.

Over the past two years, the CDD TB database has integrated the efforts of academic, non-profit, government and corporate laboratories distributed across the globe to accelerate their efforts to discover new therapies against this deadly disease.

Over the next three years, CDD will play a critical role in facilitating collaborations among leading TB researchers — now including three large pharmaceutical companies — aimed at advancing the best drug prospects. CDD will focus its powerful archiving, mining, and collaboration capabilities on supporting the workflows of screening centers searching to identify better drug leads that can be turned into more effective therapies for TB. CDD will help these collaborations work smoothly by securely sharing data among the labs and providing additional bioinformatics services to catalyze drug discovery.

"For six years CDD has focused on supporting humanitarian as well as commercial drug discovery. Now we are excited to put our new CDD Projects technology to the test. CDD Projects enables natural yet secure real-time collaborations among researchers that mimics the way people work in the pharmaceutical industry," said Barry Bunin, PhD, CEO & President of CDD.

"This project has enabled the creation of a unique database of well over 300,000 molecules with screening data against Mycobacterium tuberculosis," said Sean Ekins, PhD, Director of Collaborations. "We have also collected literature data and patent information for many compounds and freely shared this data with the research community. In addition we have enabled many groups to store and share their small molecule screening data, securely over the Internet 'in the cloud' using unique proprietary technologies."

The foundation's supplement extends the project to five years and increases the total grant to $2,796,000.

More information about the CDD TB database work and related updates can be found here.

About Collaborative Drug Discovery, Inc.

CDD hosts the most widely-used drug discovery cloud platform on the market. CDD Vault offers a private, secure industrial-strength database combining traditional drug discovery informatics (registration and SAR) with social networking capabilities. CDD Collaborate enables real-time collaboration by securely exchanging selected confidential data with external researchers. CDD Public provides free access to data that researchers have deposited in the public domain. CDD Projects enables easy management of multiple collaborations.  For more information about CDD, visit www.collaborativedrug.com.


'/>"/>
SOURCE Collaborative Drug Discovery, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
2. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
3. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
4. The Leukemia & Lymphoma Society and Anjin Group Announce Multi-Year Collaborative Research Agreement
5. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
6. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
7. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
8. Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research
9. iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering
10. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
11. Medco, State of Illinois and Community Retail Pharmacies Launch Wired Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
Breaking Medicine News(10 mins):